← Leaderboards
Naureen Tareen
Charles R. Drew University Of Med &Sci
$2,912,833
Attributed
$2,912,833
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $866.2K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$2,912,833 · 12
By mechanism
U54$2,872,668 · 9
P20$40,165 · 3
Top collaborators
No co-investigators on record.
Most similar at Charles R. Drew University Of Med &Sci
Same institution · by research overlap
- Stanley Hsia$3,105,136
Others in their field
Top investigators on “Funding”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,479,940,681
- Leonard Freedman · Leidos Biomedical Research, Inc.$968,195,877
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Jeffrey P Krischer · University Of South Florida$358,470,093
Research focus
FundingProteinsThickComputer Retrieval Of Information On Scientific Projects DatabaseUnited States National Institutes Of HealthResourcesResearch PersonnelSourceUrinaryGrantBlood VesselsDiabetes MellitusInstitutionExcretory FunctionIntima MediaDiabetic NephropathyDiabeticCardiovascular SystemDeteriorationMicroalbuminuriaGlucoseFunctional OutcomesCommunitiesCardiovascular Diseases
Grant awards (12)
CLINICAL TRIAL: END-IT$40,591
U54 · FY2009 · RR · contact PI
CLINICAL TRIAL: END-IT$1,597
P20 · FY2009 · RR · contact PI
CLINICAL TRIAL: EARLY NEPHROPATHY STUDY IN DIABETES (END-IT)$397,338
U54 · FY2008 · RR · contact PI
CLINICAL TRIAL: END-IT$250,426
U54 · FY2008 · RR · contact PI
CLINICAL TRIAL: END-IT$19,164
P20 · FY2008 · RR · contact PI
EARLY NEPHROPATHY STUDY IN DIABETES (END-IT)$301,638
U54 · FY2007 · RR · contact PI
END-IT$243,544
U54 · FY2007 · RR · contact PI
END-IT$19,404
P20 · FY2007 · RR · contact PI
END-IT$572,246
U54 · FY2006 · RR · contact PI
EARLY NEPHROPATHY STUDY IN DIABETES (END-IT)$200,733
U54 · FY2006 · RR · contact PI
END-IT$584,952
U54 · FY2005 · RR
PILOT 3- EARLY NEPHROPATHY IN DIABETES WITH RENIN-ANGIOTENSIN-ALDOSTERONE$281,200
U54 · FY2005 · RR